Michael C. Sneller, MD; Warren Strober, MD; Eli Eisenstein, MD; Jonathan S. Jaffe, MD; Charlotte Cunningham-Rundles, MD, PhD
Common variable immunodeficiency (CVI) is a heterogenous immunodeficiency syndrome characterized by hypogammaglobulinemia, recurrent bacterial infections, and various immunologic abnormalities. In addition to recurrent infections, patients with this syndrome also have an increased incidence of autoimmune disease and malignancy. Because the spectrum of associated diseases is broad, patients with CVI are seen by various medical specialists. This review discusses the pathogenesis, clinical manifestations, diagnosis, and treatment of CVI.
9. Total cellular RNA was isolated from phytohemagglutinin-stimulated cells at indicated time points, was slot blotted onto nitrocellulose filters, and was hybridized with cDNA probes for interleukin-2, -interferon, interleukin-2-R chain, and c-myc. The hybridization intensity was determined by scanning densitometry and was plotted graphically (normal persons expressed as mean SE). Only the 6-hour time point is shown for c-myc. All slot blots were hybridized with an actin probe to ensure that equal amounts of RNA had been loaded.
9. Peripheral blood lymphocytes from patients and normal persons were stimulated for 48 hours with phytohemagglutinin. Levels of interleukin-2 (IL-2) and -interferon (IFN-) in culture supernatants were then measured by specific enzyme-linked immunosorbent assays.
Purified CD4+ T cells from A) Patients with a CD4/CD8 ratio > 0.9; B) Patients with CD4/CD8 ratios < 0.9 (CD8 patients) and normal persons (controls) were stimulated with phytohemagglutinin. Supernatants were assayed for interleukin-2 (IL-2) using an enzyme-linked immunosorbent assay at 48 hours.
Normal tonsil B cells (2 10 ) were stimulated with -A Cowan's and interleukin-2 in the presence of varying numbers of CD8+ T cells from normal persons ( = 4) or CD8 patients ( = 5). After 7 days, supernatants were harvested and assayed for IgG using an enzyme-linked immunosorbent assay. The percent baseline IgG was calculated by dividing the amount of IgG produced in B-cell cultures containing CD8+ T cells by the amount of IgG produced in cultures containing only -A Cowan's interleukin-2-stimulated B cells. The percentages are expressed as mean SE for patient and control groups at each T cell/B cell ratio.
Table 1.
Terms of Use
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Sneller MC, Strober W, Eisenstein E, et al. New Insights into Common Variable Immunodeficiency. Ann Intern Med. 1993;118:720–730. doi: https://doi.org/10.7326/0003-4819-118-9-199305010-00011
Download citation file:
© 2019
Published: Ann Intern Med. 1993;118(9):720-730.
DOI: 10.7326/0003-4819-118-9-199305010-00011